Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07577674

Peer Support Intervention for Caregivers of Patients Undergoing HSCT

The main purpose of this study is to determine if a tailored peer support intervention (STEPP-Care) is feasible among caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Caregivers play a vital role in recovery following hematopoietic stem cell transplantation (HSCT). However, caregiving can contribute to psychological distress and reduced quality of life (QOL). Additionally, HSCT caregivers report low self-efficacy and social support, protective factors which would otherwise help bolster their confidence in coping with the uncertainties and challenges of HSCT. Given the challenges and unmet psychosocial needs of HSCT caregivers, peer support interventions are poised to promote caregiver coping to address caregiver distress and quality of life concerns. With limited tailored peer support interventions, for HSCT caregivers, this study aims to assess the feasibility and acceptability of a peer support intervention (STEPP-Care) and examine its preliminary effects for improving QOL, caregiver burden, and psychological well-being compared to usual care in 90 caregivers of HSCT recipients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult caregivers (≥18 years of age) of patients with hematologic malignancies who are undergoing autologous or allogeneic HSCT at Dana-Farber Cancer Institute.
  • Is a relative or friend who is identified by the patient to be their caregiver.
  • Ability to speak, read, and respond in English
  • Has access to a phone.

Exclusion criteria

  • Caregivers with acute or unstable psychiatric conditions or other cognitive conditions that the treating oncologist believes would prohibit informed consent or ability to adhere to study procedures.

Treatment and study plan

STEPP-Care

Behavioral

STEPP-Care is a phone-delivered six-session structured peer support intervention for caregivers of patients undergoing hematopoietic stem cell transplantation.

Primary outcomes

  1. Intervention Feasibility

    Time frame: up to 10 weeks

    Feasibility can be defined as >/= 60% of STEPP-Care recipients completing 4/6 sessions

  2. Intervention Acceptability

    Time frame: up to 10 weeks

    Acceptability can be defined as average STEPP-Care intervention participant ratings >20 on the Client Satisfaction Questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

Hermioni L. Amonoo, MD, MPP, MPH

CONTACT

[email protected]

617-525-7472

Josephine Monahan, BA

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Registry information

Official study title

Peer Support Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation: Feasibility and Preliminary Efficacy Trial

Acronym: STEPP-Care

Important dates

Study start
2026
Primary completion
2028
Study completion
2031
First posted
May 11, 2026
Registry last updated
May 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.